Relapsing-remitting multiple sclerosis is a type of multiple sclerosis in which you experience relapses of the disease with periods of remission occurring in between. Relapsing-remitting multiple ...

Scientists interviewed 17 patients who reported feeling unmoored by a disease that has stripped away their sense of control ...

Most people with multiple sclerosis (MS) have a type called relapsing-remitting MS (RRMS). It usually starts in your 20s or 30s. One study shows that people who began treatment when their first ...

Up to 85% of the people who receive a diagnosis of the neurodegenerative disorder multiple sclerosis (MS) have the ...

"This challenges the conventional dichotomy of multiple sclerosis into relapsing-remitting and progressive phenotypes and supports the notion that both mechanisms are present in all patients and ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

Multiple sclerosis diagnosed in people under ... Most children diagnosed with POMS receive a diagnosis of relapsing remitting MS (RRMS). RRMS involves relapses, periods during which symptoms ...

also known as relapsing-remitting MS (RRMS). According to the MS Society, in RRMS people have attacks of new and old symptoms, i.e. a relapse. RRMS is the most common type of multiple sclerosis ...

The following is a summary of “Cost–consequence analysis of early vs. delayed natalizumab use in highly active ...

Sphingosine is a membrane component in all cells and constitutes 25% of the lipid in the myelin sheath. Sphingosine is phosphorylated by ubiquitously expressed sphingosine kinases. S1P regulates ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).